Federation des caisses Desjardins du Quebec’s Takeda Pharmaceutical TAK Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$157K	Sell	9,764 -153	-2%	-$2.53K	﹤0.01%	1657
2026 Q1	$184K	Buy	9,917 +142	+1%	+$2.49K	﹤0.01%	1542
2025 Q4	$152K	Hold	9,775	–	–	﹤0.01%	1565
2025 Q3	$143K	Buy	9,775 +138	+1%	+$2.05K	﹤0.01%	1560
2025 Q2	$149K	Buy	9,637 +1,416	+17%	+$20.9K	﹤0.01%	1287
2025 Q1	$122K	Buy	8,221 +109	+1%	+$1.53K	﹤0.01%	1271
2024 Q4	$107K	Hold	8,112	–	–	﹤0.01%	1261
2024 Q3	$115K	Hold	8,112	–	–	﹤0.01%	1223
2024 Q2	$105K	Hold	8,112	–	–	﹤0.01%	1236
2024 Q1	$113K	Sell	8,112 -5,034	-38%	-$73.2K	﹤0.01%	1206
2023 Q4	$188K	Hold	13,146	–	–	﹤0.01%	971
2023 Q3	$203K	Buy	13,146 +10,068	+327%	+$156K	﹤0.01%	949
2023 Q2	$48.4K	Sell	3,078 -1,525	-33%	-$25K	﹤0.01%	1342
2023 Q1	$75.9K	Buy	4,603 +1,800	+64%	+$28.7K	﹤0.01%	1209
2022 Q4	$43.7K	Sell	2,803 -110	-4%	-$1.54K	﹤0.01%	1479
2022 Q3	$37.8K	Hold	2,913	–	–	﹤0.01%	1579
2022 Q2	$40.9K	Sell	2,913 -130	-4%	-$1.86K	﹤0.01%	1568
2022 Q1	$43.6K	Buy	3,043 +110	+4%	+$1.61K	﹤0.01%	1627
2021 Q4	$40K	Hold	2,933	–	–	﹤0.01%	1659
2021 Q3	$48K	Hold	2,933	–	–	﹤0.01%	1613
2021 Q2	$49.4K	Hold	2,933	–	–	﹤0.01%	1614
2021 Q1	$53.6K	Hold	2,933	–	–	﹤0.01%	1531
2020 Q4	$53.4K	Buy	2,933 +600	+26%	+$10.5K	﹤0.01%	1463
2020 Q3	$41.6K	Hold	2,333	–	–	﹤0.01%	1292
2020 Q2	$41.8K	Hold	2,333	–	–	﹤0.01%	1262
2020 Q1	$35.4K	Sell	2,333 -251	-10%	-$4.55K	﹤0.01%	1354
2019 Q4	$51K	Sell	2,584 -65	-2%	-$1.24K	﹤0.01%	1515
2019 Q3	$45.6K	Hold	2,649	–	–	﹤0.01%	1491
2019 Q2	$46.9K	Hold	2,649	–	–	﹤0.01%	1508
2019 Q1	$54K	Buy	+2,649	New	+$53.3K	﹤0.01%	1306

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's TAK Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec reduced its Takeda Pharmaceutical (TAK) stake by 1.5% in Q2 2026, selling an estimated $2.53K and leaving 9,764 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #1657.

Federation des caisses Desjardins du Quebec first reported a position in TAK in Q1 2019 and has held it in 30 quarters since. The position peaked at $203K in Q3 2023. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Federation des caisses Desjardins du Quebec held 9,764 shares of Takeda Pharmaceutical worth $157K as of Q2 2026.
Federation des caisses Desjardins du Quebec sold 153 Takeda Pharmaceutical shares in Q2 2026, an estimated $2.53K.
Takeda Pharmaceutical made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1657 holding.
Federation des caisses Desjardins du Quebec first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 30 quarters since.
Federation des caisses Desjardins du Quebec's Takeda Pharmaceutical position peaked at $203K in Q3 2023.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.